RISE THERAPEUTICS INC.

General Information

Official company information

Registry ID: 2533802
Company Age: 8 years
Registration Date: 25 August 2016
Registered Address: 1405 Research Boulevard Suite 220, Rockville, MD 20850, United States
Business Number (BN): 754762094
City: NEWMARKET
Status Notes: 2016-08-25
Email: N/A
Phone: +18881234567
Website: www.risetherapeutics.com

Official company website with more information about products, services, and contact details.

About RISE THERAPEUTICS INC.

Company profile and description

Rise Therapeutics is a biotechnology company developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. They focus on creating immune-modulatory drugs targeting autoimmune diseases and cancer. Founded in 2014, the company leverages expertise in synthetic biology and immunological drug development to create novel cellular-based immune therapies, including their Oral Immune BioModulators. Their product development includes in-house GMP manufacturing. They have completed dose escalation enrollment stages for both its R-2487 (rheumatoid arthritis) and R-3750 (ulcerative colitis) clinical trials. Rise Therapeutics's primary industry is Drug Discovery.

Additional Information

Detailed company information and status

Version: 1762887031717888136
Hierarchy: parent
Entity Type: ONTARIO BUSINESS CORP.
Display Date: 2016-08-25
Jurisdiction: ON
Business Number: 754762094
MRAS Entity Type: BCA

Company Contacts

Key contacts and leadership 5 total contacts

Login For More

Name & Position	Email	Contact Number	Fax Number
G Gary Fanger Founder, President & CEO	-	-	-
C Christian Furlan Freguia Senior VP of Research	-	-	-
S Sathya Janardhanan VP of Manufacturing	-	-	-
J JANET STEPHENS Senior VP of Operations	-	-	-
S SOPHIE CHAPELLE VP of Business Development	-	-	-